The pharma giant is offering its experimental remdesivir in the running for the optimal vaccine candidate.
News
Palforzia becomes first peanut allergy drug to get US approval
The approval marks a “defining moment” for the peanut allergy community.
Pharmacists ‘embracing online channels’ for wider reach
Only 7% of pharmacists believe it is not important for their pharmacy to have an online presence.
Survey reveals ‘key barriers’ limiting PCSK9is prescribing
Just 6% of cardiologists are currently prescribing PCSK9is, despite 97% believing in their abilities.
NICE to request Aimovig evidence, appeal panel rules
NICE initially rejected NHS funding for the monoclonal antibody in January last year, deeming it “too costly” for the service.
RCPE launches strategy to improve health & patient care
The “ambitious” new strategy is dubbed “Towards 2025 Together”.
UK coronavirus info campaign launched
By last Tuesday, the death toll in China stood at more than 420, and the Chinese government had reported 20,438 confirmed cases.
BMS withdraws EU Opdivo/Yervoy application
The application was initially filed in 2018 for patients with first-line NSCLC.
GSK to join global effort to develop coronavirus vaccine
Last week WHO declared the outbreak an official global health emergency.
Rinvoq NICE approval could benefit 54,000 people
Rinvoq has already been available in the US since last August, and in Europe since December.
EMA accepts GSK’s belantamab mafodotin application
The drug was also accepted for accelerated assessment by the EMA’s Committee for Human Medicinal Products (CHMP).
Pharmacists voice concerns over Brexit medicine supplies
The survey found that almost nine in 10 pharmacists are concerned about the supply of medicines now that Brexit is underway.
Could ‘tailor-made’ vaccines halve bacterial disease rates?
The findings coincide with growing alarm at the threat of antimicrobial resistance (AMR) to common medicines, after last year a UN report revealed that if left unchecked, AMR could cause as many as 10 million deaths per year by 2050.
Givlaari, Nubeqa among Jan CHMP decisions
The committee recommended fifteen medicines for approval at its first meeting of 2020, as well as six extensions of current indications.
60% of UK unis expect Brexit to affect pharma industry relationships
The UK is expected to officially leave the European Union at 11PM tonight, January 31st.
